Clinical trial
Combination Chemotherapy in Treating Children With Neuroblastoma
NCT00003093 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003093 |
|---|---|
| Title | Combination Chemotherapy in Treating Children With Neuroblastoma |
| Official title | Treatment for Infants and Children With Intermediate Risk Neuroblastoma: A Phase III Intergroup CCG/POG Study |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neuroblastoma |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, sargramostim, carboplatin, cyclophosphamide, doxorubicin hydrochloride, etoposide, conventional surgery, neoadjuvant therapy |
| Enrollment | 573 |
| Start date | Mar 1, 1988 |
| Primary completion | Sep 1, 2006 |
| Completion | Jan 1, 2011 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 1, 2014 |
| Countries | Australia, Canada, Netherlands, New Zealand, Puerto Rico, Switzerland, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: